Industry

NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Repair From a Stroke 7 Days After Onset in Landmark Preclinical Study by University of Cincinnati and Case Western Reserve University

The independent peer-reviewed study showed improved memory as well as motor and sensory functions in rodents when treatment with NVG-291-R began 7 days after stroke onset There is currently no FDA-approved drug for the repair of damage from a stroke NVG-291, currently in a Phase 1 clinical trial in healthy human subjects, could provide a … [Read more…]

Global Skin Cancer Diagnostics & Therapeutics Market Report 2022-2027: Government Initiatives for Early Detection and Skin Cancer Treatment & Proliferation in R and D Pipelines Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Skin Cancer Diagnostics & Therapeutics Market Research Report by Disease Type (Melanoma and Non-melanoma), Type, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Skin Cancer Diagnostics & Therapeutics Market size was estimated at … [Read more…]

DYSIS Appoints Chris Arnold Chief Commercial Officer as Global Business Expands

Medical Device Leader Strengthens Executive Team, Brings Expertise in Commercial Growth NATICK, Mass.–(BUSINESS WIRE)–#cervicalcancer–DYSIS Medical Inc., an emerging biophotonics company focused on providing innovative cervical mapping technology designed to help healthcare professionals identify precancerous lesions on the cervix, today announced the appointment of Chris Arnold as Chief Commercial Officer. Mr. Arnold will lead the commercial … [Read more…]

Tallac Therapeutics Announces First Patient Dosed with TAC-001, a First-in-Class Toll-like Receptor 9 Agonist Antibody Conjugate, in a Phase 1/2 Study for Patients with Advanced Solid Tumors

— TAC-001 is the First Candidate from Tallac’s Novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) Platform to Enter the Clinic BURLINGAME, Calif.–(BUSINESS WIRE)–Tallac Therapeutics, Inc., a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer, today announced that the first patient has been dosed with TAC-001 in a Phase … [Read more…]

Innovaderm Bolsters European Presence With Two Newly-Established Operations Hubs (Spain & Poland)

Strong organic growth leads dermatology CRO to significantly augment clinical trials in EU MONTREAL–(BUSINESS WIRE)–#DermatologyCRO–Innovaderm announced today that its strategic European expansion initiative has reached a major milestone with the launch of two key centres of operations in Poland and Spain. Biotechnology and pharmaceutical companies can officially partner with the CRO’s team of experts in … [Read more…]

CAR-T Therapy Global Market Research Report 2022: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, & Multiple Myeloma – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “CAR-T Therapy Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global CAR-T therapy market is expected to grow from $1.40 billion in 2021 to $1.80 billion in 2022 at a compound annual growth rate (CAGR) of 28.6%. The market is expected to grow to $3.55 billion in 2026 at … [Read more…]

Pharmaceutical Processing Seals Global Market Report 2022: Rise in Chronic Diseases Contributing Significantly to Sector Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Processing Seals Global Market Report 2022, By Type, Material, Application” report has been added to ResearchAndMarkets.com’s offering. The global pharmaceutical processing seals market is expected to grow from $1.80 billion in 2021 to $2.03 billion in 2022 at a compound annual growth rate (CAGR) of 12.4%. The growth is mainly due to … [Read more…]

DSG and 1nHealth Partner to Enhance Patient Outreach and Enrollment Capabilities

MALVERN, Pa.–(BUSINESS WIRE)–DSG, Inc., a global leader of eClinical software solutions and services, along with 1nHealth, a global digital patient recruitment provider, are creating a seamless participant experience from the initial study launch to completion of study participation. This includes integrating pre-screened leads from 1nHealth’s secure platform into DSG’s eCaseLink Enrollment Tracker to allow participants … [Read more…]

VAST Data Accelerates CeGaT Genetic Data Analytics, Delivering Medical Insights Significantly Faster Than Competing Hybrid Storage Solution

New all-flash data platform enables global genetic data analytics factory to quickly make discoveries from massive volumes of genomics sequence data, fueling medical breakthroughs Remote-First-Company/NEW YORK–(BUSINESS WIRE)–VAST Data, the data platform company for the AI-powered world, today announced the company was selected by CeGaT to accelerate time-to-insight for genetic analytics essential to diagnostic healthcare, genetic … [Read more…]

Ozette Announces $26MM in Series A Funding for AI-Powered Single-Cell Immune Discovery Technology that Accelerates Therapeutics Across Research and Development

Ozette’s proprietary technology eliminates manual gridlock and provides unmatched speed, resolution, and reproducibility to unlock immunotherapy breakthroughs from pre-clinical to post-market. SEATTLE–(BUSINESS WIRE)–Ozette Technologies, Inc., a technology-driven life sciences startup engineering a transformative leap in cell discovery and annotation of the human immune system, today announced its $26MM Series A funding, led by Madrona Ventures. … [Read more…]